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ABSTRACT 
 
Objective: The present study was designed to observe the depression, anxiety, stress and cognition levels in 
hypertensive patients. Materials and Methods: 30 Patients with pre hypertension to stage-1 hypertension, and 30 
healthy, age matched controls, including both males and females, were included in the study after obtaining written 
and informed consent.DASS-42 was used to assess depression, anxiety and stress and MMSE and spatial and verbal 
memory test was used to assess cognition. Results: Significant increase in depression, anxiety and stress and 
impaired cognitive functions were observed in hypertensive patients. Conclusion: We have observed significant 
decline in the cognitive functions and increase stress, depression and anxiety scores in the hypertensive’s. We urge 
clinicians to assess the negative emotions and cognitive functions and also consider management of these functions 
as a part of the treatment. 
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Introduction 
 
According to new classification, high normal blood 
pressure (BP) [systolic BP (SBP) 130–139 mmHg or 
diastolic BP (DBP) 80–89 mmHg] patients fall into the 
category of prehypertensive [1] and Stage 1 
hypertension patients (SBP 140–159 mmHg or DBP 
90–99 mmHg). [2,3] The relationship between 
hypertension and cognitive function is controversial.[4] 
Most of the longitudinal studies demonstrated that 
higher blood pressure causes decline in cognitive 
functions.[4] Poorly controlled hypertension leads to 
vascular dementia.[5] One third of the hypertensive 
patients were depressed and earlier studies suggested 
interventions for hypertensive’s to manage 
depression.[6] In contrary, other study reported that, 
hypertension is associated with anxiety but not 
depression.[7] It was reported that, stress can lead to 
repeated blood pressure elevations, which eventually 
may lead to hypertension.[8] The present study was 
designed to observe the depression, anxiety, stress and 
cognition levels in hypertensive patients. 
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Materials and methods 
 
Patients and controls 
30 Patients with pre hypertension to stage-1 
hypertension, and 30 healthy, age matched controls, 
including both males and females, were included in the 
study after obtaining written and informed consent. 
The following criteria were followed while selecting 
the patients as cases. 
 
Inclusion and exclusion criteria 
Inclusion criteria 
Willing male and female patients initially diagnosed 
with pre hypertension to stage-1 hypertension were 
included in the study. 
Exclusion criteria 
1. Patients with any other severe complications. 
2. Patients following relaxation methods 
3. Unwilling patients 
After recording the demographic information, all the 
healthy subjects (controls) and patients (cases) were 
familiarized with the cognition tests and recorded their 
cognitive functions. 
Setting: The study was conducted at Department of 
General Medicine, Andhra Medical College, 
Vishakapatnam, Andhra Pradesh. All the values were 
recorded in the morning for the convenience of the 
participants. 
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Tests for assessment of cognitive functions 
Verbal and spatial memory test: It was a standard 
test to assess spatial and verbal memory.[9] 
The Mini Mental State Examination (MMSE): It is a 
tool that can be used to systematically and thoroughly 
assess mental status. It is an 11-question measure that 
tests five areas of cognitive function: orientation, 
registration, attention and calculation, recall, and 
language. The maximum score is 30. A score of 23 or 
lower is indicative of cognitive impairment. The 
MMSE takes only 5-10 minutes to administer and is 
therefore practical to use repeatedly and routinely.[10] 
Assessment of depression, anxiety and stress 
Depression Anxiety and Stress Scale (DASS) [11] was 
used to assess depression, anxiety and stress.  
Statistical analysis: Data was analyzed by using SPSS 
20.0 by using student “t” test. P value less than 0.05 
was considered as significant. 
 
Results 
Table 1 presents demographic profile of the cases and 
controls. No significant difference was observed 
between cases and controls. Table 2 presents cognitive 
functions of cases and controls. Significant impaired 
MMSE scores, spatial and verbal memory scores were 
observed in cases. Table-3 presents depression, anxiety 
and stress levels in cases and controls. We have 
observed significantly higher levels of depression, 
anxiety and stress levels in hypertensive participants. 
 
Table 1:  Demographic profile of the cases and controls 
Parameter Cases (n=30) Controls (n=30) 
Age* 47.82±5.44 49.71±4.53 
Gender (Male: female) 20:10 19:11 
Height* 152.21 ± 25.36 154.76 ± 23.72 
Weight* 71±16.44 68±17.69 
*Values are expressed in Mean ± SD. There is no statistically significant difference in between groups. 
Table 2: Cognitive functions in cases and controls 
Parameter Cases (n=30) Controls (n=30) P value 
MMSE 19.0±4.77 24.00±3.84 <0.0001### 
Spatial Memory 2.66±1.58 6±3.11 <0.0001### 
Verbal Memory 2.81±1.98 6.7±2.64 <0.0001### 
Data was expressed as Mean ± SD. (#P<0.05, ##P<0.01,### 
Table no: 3 Depression, anxiety and stress levels in cases and controls 
Parameter Cases (n=30) Controls (n=30) P value 
Depression 22±5.31 14±3.99 <0.0001*** 
Anxiety 18.76±1.33 9.43±2.52 <0.0001*** 
Stress 27.11±2.66 17.34±3.48 <0.0001*** 
Data was presented as Mean±SD. (*P<0.05, **P<0.01,***P<0.001) 
 
Discussion 
Earlier studies reported that depression is common in 
patients with uncontrolled hypertension screening for 
depression in hypertensive patients is a simple and 
cost-effective tool. [12]  Depression, anxiety and stress 
are commonly experienced by hypertensive patients 
and many studies highlited the need of assessment and 
management of negative emotions in hypertension 
patients.[13] Our study further supports earlier studies 
as we have observed significant increase in the 
depression, anxiety and stress levels in patients with 
hypertension. Hypertension causes vascular changes in 
the brain which causes ischemia of brain areas 
associated with cognition and leads to vascular 
cognition impairment.[14-19] Our study further 
supports earlier studies as we have observed significant 
decline in the cognitive functions in hypertensive 
patients. 
Limitations 
The major limitation was less sample size and we have 
not assessed biomarkers of stress. Generalization of the 
results may not be possible as the study conducted at 
one centre only. 
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Conclusion 
We have observed significant decline in the cognitive 
functions and increase stress, depression and anxiety 
scores in the hypertensive’s. We urge clinicians to 
assess the negative emotions and cognitive functions 
and also consider management of these functions as a 
part of the treatment. 
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